This is a preview of subscription content, log in via an institution to check access.
Notes
2014 Canadian dollars
Reference
Atwood M, et al. Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults. Canadian Journal of Public Health. Revue Canadienne de Sante Publique : 9 May 2018. Available from: URL: https://doi.org/10.17269/s41997-018-0050-9
Rights and permissions
About this article
Cite this article
Funding two pneumococcal vaccines cost effective in Canada. PharmacoEcon Outcomes News 807, 15 (2018). https://doi.org/10.1007/s40274-018-5094-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5094-9